Antigen targeting to dendritic cells with bispecific antibodies

Journal of Immunological Methods

Volumn 306, Issue 1-2, 2005, Pages 80-92

  Wang, Welson W ^a   Das, Dipankar ^a   Tang, Xin L ^a,b   Budzynski, Wladyslaw ^a,c   Suresh, Mavanur R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b SciMed Laboratories Inc   (Canada)

^c Inimex Pharmaceuticals Inc   (Canada)

Author keywords

Antigen targeting; Bispecific monoclonal antibody; DEC 205; Dendritic cells; Immunotargeting

Indexed keywords

BIOTIN; CD40 LIGAND MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY COMBINING SITE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BINDING AFFINITY; BIOTINYLATION; BONE MARROW CELL; CANCER THERAPY; CELL SORTER; CELLULAR IMMUNITY; CONCENTRATION (PARAMETERS); CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE; HUMORAL IMMUNITY; HYBRIDOMA; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PURIFICATION;

ANIMALS; ANTIBODIES, BISPECIFIC; ANTIGEN PRESENTATION; ANTIGENS; ANTIGENS, CD; BIOTIN; BIOTINYLATION; DENDRITIC CELLS; FEMALE; HYBRIDOMAS; LECTINS, C-TYPE; MICE; MICE, INBRED C57BL; POLYETHYLENE GLYCOLS; RECEPTORS, CELL SURFACE;

ANIMALIA;

EID: 28544442289     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2005.07.023     Document Type: Article

References (43)

1. B. Almand, J.R. Resser, B. Lindman, S. Nadaf, J.I. Clark, E.D. Kwon, D.P. Carbone, and D.I. Gabrilovich Clinical significance of defective dendritic cell differentiation in cancer Clin. Cancer Res. 6 2000 1755
2. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245
3. J. Banchereau, A.K. Palucka, M. Dhodapkar, S. Burkeholder, N. Taquet, A. Rolland, S. Taquet, S. Coquery, K.M. Wittkowski, N. Bhardwaj, L. Pineiro, R. Steinman, and J. Fay Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine Cancer Res. 61 2001 6451
4. B. Bodey, B. Bodey Jr., S.E. Siegel, and H.E. Kaiser Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents Curr. Pharm. Des. 6 2000 261
5. L. Bonifaz, D. Bonnyay, K. Mahnke, M. Rivera, M.C. Nussenzweig, and R.M. Steinman Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance J. Exp. Med. 196 2002 1627
6. L.C. Bonifaz, D.P. Bonnyay, A. Charalambous, D.I. Darguste, S. Fujii, H. Soares, M.K. Brimnes, B. Moltedo, T.M. Moran, and R.M. Steinman In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination J. Exp. Med. 199 2004 815
7. Y. Cao, and L. Lam Bispecific antibody conjugates in therapeutics Adv. Drug Deliv. Rev. 55 2003 171
8. Y. Cao, and M.R. Suresh Bispecific antibodies as novel bioconjugates Bioconjug. Chem. 9 1998 635
9. Y. Cao, S. Christian, and M.R. Suresh Development of a bispecific monoclonal antibody as a universal immunoprobe for detecting biotinylated macromolecules J. Immunol. Methods 220 1998 85
10. V. Cerundolo, I.F. Hermans, and M. Salio Dendritic cells: a journey from laboratory to clinic Nat. Immunol. 5 2004 7
11. B. Chen, Y. Shi, J.D. Smith, D. Choi, J.D. Geiger, and J.J. Mule The role of tumor necrosis factor alpha in modulating the quantity of peripheral blood-derived, cytokine-driven human dendritic cells and its role in enhancing the quality of dendritic cell function in presenting soluble antigens to CD4+ T cells in vitro Blood 91 1998 4652
12. J.E. Coligan A.M. Kruisbeek D.H. Margulies W. Strober Current Protocols in Immunology 1995 Wiley 1.7.1
13. M.K. Collins, and V. Cerundolo Gene therapy meets vaccine development Trends Biotechnol. 22 2004 623
14. D. Das, and M.R. Suresh Producing bispecific and bifunctional antibodies Methods Mol. Med. 109 2005 329
15. J.M. Den Haan, S.M. Lehar, and M.J. Bevan CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo J. Exp. Med. 192 2000 1685
16. R. Dong, K. Cwynarski, A. Entwistle, F. Marelli-Berg, F. Dazzi, E. Simpson, J.M. Goldman, J.V. Melo, R.I. Lechler, I. Bellantuono, A. Ridley, and G. Lombardi Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration Blood 101 2003 3560
17. D.I. Gabrilovich, J. Corak, I.F. Ciernik, D. Kavanaugh, and D.P. Carbone Decreased antigen presentation by dendritic cells in patients with breast cancer Clin. Cancer Res. 3 1997 483
18. T. Garrity, R. Pandit, M.A. Wright, J. Benefield, S. Keni, and M.R. Young Increased presence of CD34+ cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells Int. J. Cancer 73 1997 663
19. D. Hawiger, K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J.V. Ravetch, R.M. Steinman, and M.C. Nussenzweig Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo J. Exp. Med. 194 2001 769
20. K. Inaba, W.J. Swiggard, M. Inaba, J. Meltzer, A. Mirza, T. Sasagawa, M.C. Nussenzweig, and R.M. Steinman Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145: I. Expression on dendritic cells and other subsets of mouse leukocytes Cell. Immunol. 163 1995 148
21. W. Jiang, W.J. Swiggard, C. Heufler, M. Peng, A. Mirza, R.M. Steinman, and M.C. Nussenzweig The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing Nature 375 1995 151
22. R. Koelemij, P.J. Kuppen, C.J. van de Velde, G.J. Fleuren, M. Hagenaars, and A.M. Eggermont Bispecific antibodies in cancer therapy, from the laboratory to the clinic J. Immunother. 22 1999 514
23. B.J. Kroesen, J. Nieken, D.T. Sleijfer, G. Molema, E.G. de Vries, H.J. Groen, W. Helfrich, T.H. The, N.H. Mulder, and L. de Leij Approaches to lung cancer treatment using the CD3 × EGP-2-directed bispecific monoclonal antibody BIS-1 Cancer Immunol. Immunother. 45 1997 203
24. F. Liu, S. Guttikonda, and M.R. Suresh Bispecific monoclonal antibodies against a virus and an enzyme: utilities in ultrasensitive virus ELISA and phage display technology J. Immunol. Methods 274 2003 115
25. M.B. Lutz, N. Kukutsch, A.L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow J. Immunol. Methods 223 1999 77
26. K. Mahnke, M. Guo, S. Lee, H. Sepulveda, S.L. Swain, M. Nussenzweig, and R.M. Steinman The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments J. Cell Biol. 151 2000 673
27. E.M. Neidhardt-Berard, F. Berard, J. Banchereau, and A.K. Palucka Dendritic cells loaded with killed breast cancer cells induce differentiation of tumor-specific cytotoxic T lymphocytes Breast Cancer Res. 6 2004 322
28. F.O. Nestle, J. Banchereau, and D. Hart Dendritic cells: on the move from bench to bedside Nat. Med. 7 2001 761
29. T. Ninomiya, S.M. Akbar, T. Masumoto, N. Horiike, and M. Onji Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma J. Hepatol. 31 1999 323
30. A. Nisonoff, and M.M. Rivers Recombinant of a mixture of univalent antibody fragments of different specificity Arch. Biochem. Biophys. 93 1961 460
31. M.J. Palmowski, E.M. Choi, I.F. Hermans, S.C. Gilbert, J.L. Chen, U. Gileadi, M. Salio, A. Van Pel, S. Man, E. Bonin, P. Liljestrom, P.R. Dunbar, and V. Cerundolo Competition between CTL narrows the immune response induced by prime-boost vaccination protocols J. Immunol. 168 2002 4391
32. B. Pulendran, K. Palucka, and J. Banchereau Sensing pathogens and tuning immune responses Science 293 2001 253
33. S. Satthaporn, A. Robins, W. Vassanasiri, M. El-Sheemy, J.A. Jibril, D. Clark, D. Valerio, and O. Eremin Dendritic cells are dysfunctional in patients with operable breast cancer Cancer Immunol. Immunother. 53 2004 510
34. B. Schuler-Thurner, E.S. Schultz, T.G. Berger, G. Weinlich, S. Ebner, P. Woerl, A. Bender, B. Feuerstein, P.O. Fritsch, N. Romani, and G. Schuler Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells J. Exp. Med. 195 2002 1279
35. T. Schwaab, A.R. Schned, J.A. Heaney, B.F. Cole, J. Atzpodien, F. Wittke, and M.S. Ernstoff In vivo description of dendritic cells in human renal cell carcinoma J. Urol. 162 1999 567
36. M.R. Suresh, A.C. Cuello, and C. Milstein Advantages of bispecific hybridomas in one-step immunocytochemistry and immunoassays Proc. Natl. Acad. Sci. U. S. A. 83 1986 7989
37. X.L. Tang, M.S. Peppler, R.T. Irvin, and M.R. Suresh Use of bispecific antibodies in molecular velcro assays whose specificity approaches the theoretical limit of immunodetection for Bordetella pertussis Clin. Diagn. Lab. Immunol. 11 2004 752
38. M. Thurnher, C. Radmayr, R. Ramoner, S. Ebner, G. Bock, H. Klocker, N. Romani, and G. Bartsch Human renal-cell carcinoma tissue contains dendritic cells Int. J. Cancer 68 1996 1
39. C.L. Van Broekhoven, C.R. Parish, C. Demangel, W.J. Britton, and J.G. Altin Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy Cancer Res. 64 2004 4357
40. H.H. Van Ojik, and T. Valerius Preclinical and clinical data with bispecific antibodies recruiting myeloid effector cells for tumor therapy Crit. Rev. Oncol./Hematol. 38 2001 47
41. H. Wang, Y. Liu, L. Wei, and Y. Guo Bi-specific antibodies in cancer therapy Adv. Exp. Med. Biol. 465 2000 369
42. S. Withoff, W. Helfrich, L.F. de Leij, and G. Molema Bi-specific antibody therapy for the treatment of cancer Curr. Opin. Mol. Ther. 3 2001 53
43. M.D. Witmer-Pack, W.J. Swiggard, A. Mirza, K. Inaba, and R.M. Steinman Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145: II. Expression in situ in lymphoid and nonlymphoid tissues Cell. Immunol. 163 1995 157